Follicle Stimulating Hormone (FSH) Receptor Polymorphisms in In-Vitro Fertilization Cycles.
Launched by UNIVERSITY REPRODUCTIVE ASSOCIATES · Oct 26, 2009
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
All IVF patients who meet inclusion criteria and not exclusion criteria will be asked to participate in this study. Upon consent, a blood sample will be obtained in 2 EDTA containing lavender topped tubes before, during or within 3 months after their IVF cycle. Genomic DNA will be extracted and saved for genotyping.
The Investigators will collect data on each individual's age, ethnic background, and estradiol levels on the day of hCG administration, total gonadotropin amount, clinical pregnancy rates, basal FSH levels, and occurrence of OHSS. The Investigators will then analyze all samples...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. 100 women less than 35 years old at time of signing the Informed Consent Form.
- • 2. Day 3 FSH level less than or equal to 10 mIU/ml with an estradiol \< 70 pg/ml
- • 3. Day 3 antral follicle count of greater than 10 follicles total.
- • 4. Couples who have male factor infertility, tubal factor infertility, and unexplained infertility.
- Exclusion Criteria patients who have:
- • 1. Endometriosis
- • 2. Polycystic ovarian syndrome
About University Reproductive Associates
University Reproductive Associates is a leading clinical trial sponsor specializing in reproductive health and fertility research. Committed to advancing the field of reproductive medicine, the organization collaborates with academic institutions and healthcare providers to conduct innovative clinical trials that aim to improve patient outcomes and enhance treatment options. With a focus on evidence-based practices, University Reproductive Associates is dedicated to fostering scientific discovery and translating research findings into effective clinical applications, ultimately contributing to the well-being of individuals and families seeking reproductive assistance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hasbrouck Heights, New Jersey, United States
Hoboken, New Jersey, United States
Patients applied
Trial Officials
Aimee Seungdamrong, MD
Principal Investigator
University Reproductive Associates
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials